Anzeige
Mehr »
Login
Freitag, 04.04.2025 Börsentäglich über 12.000 News von 693 internationalen Medien
Warum Almonty Industries zum Schlüsselplayer für NATO-Staaten wird
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 885825 | ISIN: US4525253062 | Ticker-Symbol: IUL
Frankfurt
03.04.25
08:36 Uhr
4,540 Euro
+0,060
+1,34 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
IMMUCELL CORPORATION Chart 1 Jahr
5-Tage-Chart
IMMUCELL CORPORATION 5-Tage-Chart

Aktuelle News zur IMMUCELL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
IMMUCELL Aktie jetzt für 0€ handeln
MiImmuCell Corporation: ImmuCell Announces Initiation of Investigational Product Use of Re-Tain31PORTLAND, Maine, April 02, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically...
► Artikel lesen
28.03.IMMUCELL CORP /DE/ - 10-K, Annual Report3
25.02.ImmuCell GAAP EPS of $0.06, revenue of $7.75M1
25.02.ImmuCell Corporation: ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2024103PORTLAND, Maine, Feb. 25, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically...
► Artikel lesen
25.02.IMMUCELL CORP /DE/ - 8-K, Current Report-
20.02.ImmuCell Corporation: ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 20241
16.01.ImmuCell settles insurance claim for production losses1
16.01.ImmuCell erzielt Einigung bei Versicherungsanspruch für Produktionsverluste1
16.01.ImmuCell Corporation: ImmuCell Announces Settlement of Insurance Claim Related to Previously Disclosed Production Contamination Losses255PORTLAND, Maine, Jan. 16, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically...
► Artikel lesen
10.01.IMMUCELL CORP /DE/ - 8-K, Current Report-
09.01.ImmuCell reports higher prelim Q4 sales1
09.01.ImmuCell Corporation: ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year 2024522PORTLAND, Maine, Jan. 09, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically...
► Artikel lesen
09.12.24IMMUCELL CORP /DE/ - 8-K, Current Report-
02.12.24IMMUCELL CORP /DE/ - 8-K, Current Report-
13.11.24ImmuCell Corporation: ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 202460PORTLAND, Maine, Nov. 13, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically...
► Artikel lesen
07.11.24ImmuCell Corporation: ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 20241
08.10.24ImmuCell announces preliminary results for Q3 20241
08.10.24ImmuCell reports 11% sales boost in third quarter1
08.10.24ImmuCell Corporation: ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 202494PORTLAND, Maine, Oct. 08, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically...
► Artikel lesen
08.10.24IMMUCELL CORP /DE/ - 8-K, Current Report2
Seite:  Weiter >>
24 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1